Disease: Candida albicans infections

Baicalein as a potent antifungal agent against Candida albicans: synergy with fluconazole and sustainable production through probiotic-mediated bioconversion

mycolabadmin

Baicalein, a natural compound from a traditional medicinal plant, is significantly more effective at fighting Candida albicans infections than its parent compound baicalin. When combined with the common antifungal drug fluconazole, baicalein creates a powerful synergistic effect that is especially useful against drug-resistant fungal strains. Scientists discovered that a beneficial probiotic bacterium, Lactobacillus rhamnosus, can efficiently convert the abundant baicalin into baicalein, providing a sustainable and safe way to produce this potent antifungal compound at scale.

Read More »

Extracellular Biosynthesis, Characterization and Antimicrobial Activity of Silver Nanoparticles Synthesized by Filamentous Fungi

mycolabadmin

Researchers used three types of common fungi to create tiny silver particles in an environmentally friendly way. These silver nanoparticles were found to effectively kill harmful bacteria and fungal infections. The fungus Cladosporium cladosporoides was the most effective at producing these particles, showing promise for use in medical and health applications.

Read More »

Synergistic potential and apoptosis induction of Bunium persicum essential oil and its pure components, cuminaldehyde and γ-terpinene, in combination with fluconazole on Candida albicans isolates: in vitro and in silico evaluation

mycolabadmin

Researchers studied how an essential oil from black cumin seeds (Bunium persicum) and two of its key active components could work together with the antifungal drug fluconazole to fight Candida albicans infections, including drug-resistant strains. Using laboratory tests and computer modeling, they found that cuminaldehyde, one of the main components, was particularly effective when combined with fluconazole, killing yeast cells through multiple mechanisms. This suggests that natural plant compounds could be valuable partners with conventional antifungal medications to overcome drug resistance.

Read More »

Correction to: Candida albicans—A systematic review to inform the World Health Organization Fungal Priority Pathogens List

mycolabadmin

This is a correction notice to an important scientific review about Candida albicans, a common fungal infection that affects many people worldwide. The World Health Organization requested this systematic review to help prioritize which fungal diseases are most important to address globally. The correction simply fixes an author’s name that was misspelled in the original published version of the review.

Read More »

Protein kinase A signaling regulates immune evasion by shaving and concealing fungal β-1,3-glucan

mycolabadmin

Candida albicans is a fungus that causes infections in humans. The fungus has developed a clever way to hide from our immune system by covering up a molecule on its surface called β-1,3-glucan that normally triggers immune responses. This study shows that the fungus masks this molecule through a combination of growing and dividing to create new surfaces, and then using enzymes to trim away exposed molecules. The research reveals that a specific cell signaling pathway controlled by lactate (a chemical found in our bodies) activates this masking behavior, helping the fungus evade immune recognition.

Read More »

MycoNews 2022: editorial, news, reports, awards, personalia, and book news

mycolabadmin

Mycology is experiencing rapid growth in public awareness and scientific recognition. Popular books and films about fungi have dramatically increased interest in the field. The International Mycological Community celebrated major achievements in 2022, with prominent conferences and awards recognizing outstanding research and contributions to understanding fungi’s vital roles in nature and human health.

Read More »

mGem: Submarine mycology—an analog to astromycology

mycolabadmin

Scientists are studying fungi in submarines to better understand fungal health risks for astronauts in space. Both submarines and spacecraft are enclosed environments where fungi can grow, causing infections and other health problems. The same types of fungi found growing in submarines have been detected on the International Space Station. By learning from decades of submarine research, space agencies can better prepare for and prevent fungal-related health issues during long space missions.

Read More »
Scroll to Top